PortfoliosLab logo

Akero Therapeutics, Inc. (AKRO)

Equity · Currency in USD · Last updated Jun 28, 2022

Company Info

ISINUS00973Y1082
CUSIP00973Y108
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$10.09
Year Range$8.00 - $26.24
EMA (50)$10.45
EMA (200)$16.25
Average Volume$400.26K
Market Capitalization$390.13M

AKROShare Price Chart


Chart placeholderClick Calculate to get results

AKROPerformance

The chart shows the growth of $10,000 invested in Akero Therapeutics, Inc. on Jun 21, 2019 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $5,508 for a total return of roughly -44.92%. All prices are adjusted for splits and dividends.


AKRO (Akero Therapeutics, Inc.)
Benchmark (^GSPC)

AKROReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M14.14%-6.21%
YTD-52.29%-18.17%
6M-54.03%-17.47%
1Y-63.49%-8.89%
5Y-17.94%9.65%
10Y-17.94%9.65%

AKROMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

AKROSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Akero Therapeutics, Inc. Sharpe ratio is -0.98. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


AKRO (Akero Therapeutics, Inc.)
Benchmark (^GSPC)

AKRODividend History


Akero Therapeutics, Inc. doesn't pay dividends

AKRODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


AKRO (Akero Therapeutics, Inc.)
Benchmark (^GSPC)

AKROWorst Drawdowns

The table below shows the maximum drawdowns of the Akero Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Akero Therapeutics, Inc. is 79.96%, recorded on Jun 1, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-79.96%Jul 10, 2020478Jun 1, 2022
-57.16%Aug 29, 2019139Mar 18, 202073Jul 1, 2020212
-14.83%Jun 27, 20199Jul 10, 20192Jul 12, 201911
-9.04%Jul 29, 20192Jul 30, 20196Aug 7, 20198
-8.22%Jun 24, 20192Jun 25, 20191Jun 26, 20193
-7.35%Aug 8, 20192Aug 9, 20198Aug 21, 201910
-4.22%Jul 18, 20191Jul 18, 20192Jul 22, 20193
-2.1%Jul 24, 20191Jul 24, 20191Jul 25, 20192
-2.02%Aug 22, 20192Aug 23, 20193Aug 28, 20195
-1.06%Jul 16, 20191Jul 16, 20191Jul 17, 20192

AKROVolatility Chart

Current Akero Therapeutics, Inc. volatility is 149.49%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


AKRO (Akero Therapeutics, Inc.)
Benchmark (^GSPC)

Portfolios with Akero Therapeutics, Inc.


Loading data...